179 related articles for article (PubMed ID: 36123280)
1. Liquid Biopsy for Prostate and Bladder Cancer: Progress and Pitfalls.
Groen L; Schalken J
Eur Urol Focus; 2022 Jul; 8(4):904-906. PubMed ID: 36123280
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
Chen H; Xu C; Fang Z; Mao S
Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer and liquid biopsies: Clinical applications and challenges.
Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T
Int J Urol; 2024 Jun; 31(6):617-626. PubMed ID: 38551314
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice.
Puche-Sanz I; Rodríguez-Martínez A; Garrido-Navas MC; Robles-Fernández I; Vázquez-Alonso F; Álvarez Cubero MJ; Lorente-Acosta JA; Serrano-Fernández MJ; Cózar-Olmo JM
Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):139-147. PubMed ID: 31839360
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
6. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsies: Potential and challenges.
Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
[TBL] [Abstract][Full Text] [Related]
8. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
9. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
[TBL] [Abstract][Full Text] [Related]
10. Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer.
Cimadamore A; Aurilio G; Nolé F; Massari F; Scarpelli M; Santoni M; Lopez-Beltran A; Cheng L; Montironi R
Cells; 2020 Jun; 9(6):. PubMed ID: 32575429
[TBL] [Abstract][Full Text] [Related]
11. A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.
Matuszczak M; Kiljańczyk A; Salagierski M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955727
[TBL] [Abstract][Full Text] [Related]
12. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
13. Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies.
Constâncio V; Barros-Silva D; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2019 May; 19(5):367-375. PubMed ID: 30961397
[TBL] [Abstract][Full Text] [Related]
14. Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer.
Chedgy EC; Douglas J; Wright JL; Seiler R; van Rhijn BW; Boormans J; Todenhöfer T; Dinney CP; Collins CC; Van der Heijden MS; Black PC
Urol Oncol; 2016 Oct; 34(10):469-76. PubMed ID: 27317490
[TBL] [Abstract][Full Text] [Related]
15. Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.
Trujillo B; Wu A; Wetterskog D; Attard G
Br J Cancer; 2022 Nov; 127(8):1394-1402. PubMed ID: 35715640
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
17. Blood-based liquid biopsy in advanced prostate cancer.
Giunta EF; Malapelle U; Russo A; De Giorgi U
Crit Rev Oncol Hematol; 2024 Feb; 194():104241. PubMed ID: 38122919
[TBL] [Abstract][Full Text] [Related]
18. Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
Contreras-Sanz A; Roberts ME; Seiler R; Black PC
Int J Urol; 2017 Jan; 24(1):7-15. PubMed ID: 27597124
[TBL] [Abstract][Full Text] [Related]
19. The role of liquid biopsies in prostate cancer management.
Kim CJ; Dong L; Amend SR; Cho YK; Pienta KJ
Lab Chip; 2021 Sep; 21(17):3263-3288. PubMed ID: 34346466
[TBL] [Abstract][Full Text] [Related]
20. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
Theil G; Fornara P
Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
